Cryptococcus gattii infection in healthy hosts: A sentinel for subclinical immunodeficiency?

Clinical Infectious Diseases

Volumn 54, Issue 1, 2012, Pages 153-154

  Marr, Kieren A ^a   Datta, Kausik ^a   Pirofski, Liise Anne ^b   Barnes, Robert ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c PeaceHealth Medical Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CEFTRIAXONE; DEXAMETHASONE; FLUCYTOSINE;

ADULT; ANAMNESIS; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID PRESSURE; CRANIAL NERVE; CRYPTOCOCCOSIS; CRYPTOCOCCUS GATTII; FEMALE; HEADACHE; HUMAN; IMMUNE DEFICIENCY; LETTER; PLEOCYTOSIS; PRIORITY JOURNAL;

ADULT; ANTIBODIES, FUNGAL; ASYMPTOMATIC DISEASES; CRYPTOCOCCOSIS; CRYPTOCOCCUS GATTII; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN G;

EID: 84555204840     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir756     Document Type: Letter

References (3)

1. Emergence of Cryptococcus gattii-Pacific Northwest, 2004-2010. MMWR Morb Mortal Wkly Rep 2010; 59:865-8.
2. Datta K, Bartlett KH, Baer R, et al. Spread of Cryptococcus gattii into Pacific Northwest region of the United States. Emerg Infect Dis 2009; 15:1185-91.
3. Barrett DJ, Ayoub EM. IgG2 subclass restriction of antibody to pneumococcal polysaccharides. Clin Exp Immunol 1986; 63:127-34. (Pubitemid 16196411)